La tuberculose ganglionnaire : aspects cliniques, paracliniques, thérapeutiques et évolutifs en médecine interne

Untitled

“…The outcome under anti-tuberculosis treatment was favorable in 86,9% (40/46) of our patients. These results are similar to those found in Senegal by Bourzama [29] who noted a good evolution in all his patients (100%) but also in other previous studies [5,15,21,25] which respectively reported 100%, 100 %, 95.2% and 87.5%. Classically, the evolution under regularly monitored anti-tuberculosis treatment is favorable in the majority of cases with recovery of patients marked by regression or even disappearance of lymphadenopathy.…”

“…Diop [20] in his series found tuberculosis contagion in 69.9% of his patients. In the literature, this notion of contagion is reported in 10 to 25% of patients [5]. This high proportion of tuberculosis contagion observed in our data may largely be explained by the cross-sectional nature of our study.…”

“…In our study, it was 12.1%, comparable to that found in Senegal by Elguennoumi [3] which was 12.4%. Higher frequencies were however reported in the literature [4,5,6,7,8] respectively 47.68%; 31%; 35%; 54.8 and 41%. In sub-Saharan Africa, especially in countries with a high endemicity of HIV infection, tuberculosis has experienced a marked increase in both its pulmonary and extra-pulmonary location with prevalence of up to 69% [9,10].…”

“…The duration of treatment in our study was on average 7.3 months. In the Bourzama study [29], the duration of treatment was 9 months in all patients and 6 to 10 months in the Belhadj study [5]. Hamzaoui [21] reported that 88% of his patients were treated for a period of 6 months.…”